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Abstract
Background: Central nervous system features have been rarely described to be associated with the small deletion
or duplication of chromosome 22q11.21.
Case presentation: We report two patients with chromosome 22q11.21 alterations and central nervous system
abnormalities. Features described include semilobar holoprosencephaly in the patient with the small deletion and
Chiari I malformation in the patient with the small duplication.
Conclusions: This report will aid in the characterization of the clinical significance of interstitial duplications and
deletions on the long-arm of chromosome 22. Areas of future research would benefit from additional analysis of
the described regions with inclusion of the phenotypic findings described in this case report to provide additional
insight into the pathogenicity of the described alterations.
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Array CGH, Chromosome 22q11, Deletion, Duplication
Background
We present two patients with similar, small alterations
of chromosome 22q11.21, deleted in the first and dupli-
cated in the second patient. Both patients have central
nervous system abnormalities rarely reported as fea-
tures of chromosome 22q11 deletion or duplication
syndromes. Deletions and duplications in this region
have been previously reported, and with increasing de-
tection with advancing microarray technology, more
specific genotype-phenotype associations have been de-
scribed. Information presented in this report will aid in
the characterization of the clinical significance of small
interstitial duplications and deletions on the long-arm
of chromosome 22.
Deletion of chromosome 22q11 is one of the most
widely recognized chromosomal microdeletions. With
an incidence of approximately 1/4000 live births, it is
the most common, known microdeletion [1]. It is esti-
mated that 5–10 % of cases are inherited, with the
remainder being de novo. The 22q11 deletion syndrome
is associated with a spectrum of features, including
congenital heart defects, palatal abnormalities, charac-
teristic facial features, learning difficulties, and immune
deficiency [2]. It has also been associated with an in-
creased risk for major psychiatric disorders, particularly
schizophrenia [3, 4].
Central nervous system malformations
Central nervous system malformations, such as holo-
prosencephaly, are rarely reported with 22q11 deletion
syndrome. Often only associated features, such as single
median incisor, have been reported in previous case
reports. Solitary median central incisor may be an iso-
lated finding, but has also been associated with holo-
prosencephaly [5]. In 1997, Hall et al. reported a series
of 21 cases involving solitary median central incisor, one
case of which was later diagnosed with 22q11 deletion
syndrome [6]. In 2005, Yang et al. reported a patient with
DiGeorge syndrome who was found to have a solitary me-
dian central incisor [7]. In a national retrospective study
of feto-pathological examinations following a molecular
diagnosis of 22q11 deletion, Noel et al. found 10 out of
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64 cases had neurological defects, including five with
arhinencephalies, another term for holoprosencephaly
[8]. Thus, reports of documented holoprosencephaly in
patients with 22q11 deletion syndrome have been rarely
reported.
Duplication of chromosome 22q11 is also character-
ized by highly variable features, which may range from
normal to mild and may include intellectual disability
or learning disabilities, growth retardation, hypotonia,
and delayed psychomotor development [9]. Parental
testing in prior studies has revealed a high proportion
of familial duplications with highly variable parental
features [10]. While population data is extremely limited,
studies have estimated that duplications are approximately
half as common as deletions [10]. However, it is unknown
if this is due to the variability of features resulting in ascer-
tainment bias. While Chiari I malformation has been pre-
viously reported in 22q11 deletion syndrome [11], this is
the first report, to our knowledge, of a patient with 22q11
duplication and Chiari I malformation.
Molecular genetics of 22q11.21
The frequent and homogeneous deletions and duplica-
tions involving chromosome 22q11 has been attributed
to the high number of low copy repeats (LCR) in the
region, which results in frequent meiotic homologous
recombination events [12]. Most patients with 22q11
deletions or duplications have a common 3 megabase
(Mb) deletion or a smaller, distal nested 1.5 Mb dele-
tion [13]. The 3 Mb deletion is found in approximately
90 % of individuals with 22q11 deletion syndrome and
contains approximately 40 genes, including the gene
TBX1 which has been associated with several main fea-
tures of 22q11 syndrome including characteristic facial
features, cardiac defects, thymic hypoplasia, velophar-
yngeal insufficiency with cleft palate, and parathyroid
dysfunction with hypocalcaemia [2, 13–15]. The 1.5 Mb
“nested” deletion is located within the 3 Mb deleted region
and includes at least 28 genes including TBX1 [3, 14, 16].
Recent studies have suggested a higher proportion of
maternal origin of de novo deletions [17]. Microduplica-
tions in this region most commonly include the same
3 Mb region commonly found to be deleted in 22q11
deletion syndrome, though duplication of the smaller,
nested 1.5 Mb region and distal duplications have also
been reported [10].
Testing for 22q11 deletion syndrome has traditionally
been accomplished by fluorescence in situ hybridization
(FISH) analysis, commonly using the TUPLE1 probe
(Vysis/Abbott Laboratories). While traditional FISH ana-
lysis will detect the above described small, nested 1.5 Mb
deletion, it will not detect other small deletions in this re-
gion such as those described below. Thus, microarray
analysis has become more commonly utilized when 22q11
deletion syndrome is suspected. With the increase in
utilization of microarray, there has been an increase in re-
ports of small deletions not previously detected by FISH
analysis.
Out of approximately 7000 samples referred for a var-
iety of indications, the Baylor Cytogenetics laboratory
identified 59 individuals with either gains or losses in
the 22q11.2 region. Of the 40 individuals with a detected
deletion, 33 were the common 3 Mb microdeletion, one
was the 1.5 Mb microdeletion, and five had atypical de-
letions. Of the 19 individuals with duplication, 10 had
the 3 Mb microduplication and 9 had smaller duplica-
tions. Of the smaller microduplications, two were identi-
fied as the common, smaller, nested 1.5 Mb duplication
and 7 were unique, including a 1 Mb “nested” duplication
from LCR22-3a through LCR22-4, a 1 Mb distal microdu-
plication from LCR22-4 through LCR 22-5, and a 2 Mb
distal microduplication from LCR22-4-LCR22-6 [10]. Clin-
ical significance of small duplications of 22q11 remains
unclear, as there are few reports of duplications of this area
of chromosome 22.
Case presentation
Case 1: small duplication 22q11.21
An order was received for microarray based, compara-
tive genomic hybridization (array CGH) on a 3 year-old
female due to a delay in social and language develop-
ment and question of features of autism spectrum dis-
order. The patient received regular speech therapy due
to speech delay (reported to not speak) and occupa-
tional therapy. Review of medical records revealed that
a hearing evaluation had not been performed due to
lack of cooperation. Her diagnoses included attention
deficit-hyperactivity disorder, autism spectrum disorder
and sensory processing disorder, and developmental
language disorder. The patient’s gross motor skills were
within the normal range. Normal vision was reported
by the parents, but no formal evaluation had been per-
formed. Normal muscle tone and growth was reported
by the pediatrician. Orthopedic evaluation revealed no
orthopedic concerns. Genetics evaluation revealed no
dysmorphic features. The patient was reported to have
a latex allergy. Echocardiogram was performed with a
normal result. Magnetic resonance imaging (MRI) of
the brain revealed Chiari I malformation resulting in
moderate effacement of the cerebrospinal fluid space at
the cervicomedullary junction. Findings revealed that
the cerebellar tonsils project approximately 9 mm into
the foramen magnum. See Table 1 for a comparison of
the patient’s features to features of 22q11 duplication
syndrome described previously.
The patient had one full brother who was 4 years-old
and was reported to be healthy with no developmental
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concerns. Her mother was reported to have had a pa-
tent ductus arteriosus (PDA) and patent foramen ovale
(PFO) not requiring surgical repair and a history of mi-
graines. She was currently 23 years of age with no
major health or developmental concerns. Maternal fam-
ily history was significant for a cousin with a 5 year-old
daughter with autism. Maternal ethnic background was
Caucasian (German and Irish) and Native American
(Comanche). The father was 25 years of age and re-
ported to be healthy with normal development. There
was no known paternal history of developmental delays,
autism, or congenital anomalies. Paternal ethnic back-
ground was Portuguese and Hawaiian. Consanguinity
was denied.
Conventional and molecular cytogenetics
Array CGH revealed an approximately 115 kb duplication
of chromosome 22q11.21 [arr 22q11.21 (18,894,835–
19,010,562) × 3] (Fig. 1). Parental analysis was not per-
formed at the time of this report because the family
declined further testing. No additional family members
had been tested at the time of this report.
A review of DECIPHER (DECIPHER, https://decipher.-
sanger.ac.uk/) on 5/19/2015 revealed a reported case
(285769) of a similar duplication (22:18894835-19010508).
However, a second sequence variant (1:187074685-
248262713) is also reported and is classified as definitely
pathogenic. Phenotypic features include abnormality of
the ear, abnormality of the tricuspid valve, aneurysm, duo-
denal atresia, global developmental delay, narrow mouth,
palpebral fissure narrowing on adduction, and thin lips.
Decipher case 285666 was also identified as having a simi-
lar duplication (chr22:18889039-19010508). Phenotypic
features reported include delayed speech and language
development, global developmental delay, hypertelorism,
low-set ears, motor delay, narrow mouth, short nose, single
transverse palmar crease, spontaneous neonatal pneumo-
thorax, and thick lower lip vermilion. However, this case
also included three additional alterations (chr8:141415657-
146174033, chr10:134001731-135372492, and chr22:16053
473-17297403).
Table 1 Features seen in Case 1 compared to 22q11 duplication syndrome and in Case 2 compared to 22q11 deletion syndrome
Feature 22q11 duplication
syndrome
Case 1 22q11 deletion
syndrome
Case 2
Craniofacial abnormalities x - + microcephalic, plageocephalic,
overriding sutures, hypotelorism,
and depressed nasal bridge
Congenital heart defect x - conotruncal
malformations
small patent ductus arteriosus
Palatal defect NR + cleft lip, absent nasal septum,




Hearing loss x - + NR




x NR + NR




Autism spectrum disorder + + NR
Behavioral problems x NR + NR
Speech delay x + + NR
Growth delay x NR + NR
Hypotonia x NR + truncal and appendicular
hypotonia





Immune deficiency + NR
NR not reported, + feature present, − feature absent
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Comparison of these previously reported cases in Decipher
is limited by the presence of additional alterations, which
are absent in the presented patient, Case 1. Given the
significant phenotypic variability previously reported to be
associated with chromosome 22q11 duplication, it is
unclear if the described phenotypes in these prior cases
are due to the similar 22q duplication or due to the
additional alterations present in these prior cases. Thus,
Case 1 reported here is unique in the presence of only this
small duplication region.
Case 2: small deletion 22q11.21
An order for array CGH was received on this two-day
old infant following a genetics hospital consultation for
seizures and dysmorphic features, specifically unilateral
midline defects including cleft lip, absent nasal septum,
and cleft maxilla papilla. On exam, she was noted to
have overriding sutures, hypotelorism, and a depressed
nasal bridge. This female infant was born at 36 weeks
gestation to a 21 year-old Caucasian (Irish and German)
mother who reported a history of childhood seizures,
arthritis, and attention deficit hyperactivity disorder, and
a 29 year-old Caucasian (German and Irish) father with
a history of possible myocardial infarction, congenital
clubfoot, and “sandal gap” toes. Prenatal care included
normal maternal serum screening, no reported alcohol
or drug use, and reported significant for preeclampsia.
Birth weight was 4 lbs, 6.9 oz with Apgar scores of 8 at
1 min and 9 at 5 min. Her head circumference was
noted to be 29.0 cm (< 3 %) at two days-old. Consan-
guinity was denied. Father’s family history was significant
for a deceased brother at 12 years-old with an unknown
type of heart disease. Paternal family history also in-
cluded a report of the paternal grandfather and cousins
with seizure disorders and an uncle with aortic
dissection. Maternal history was significant for a mater-
nal great aunt with early death due to a “hole in the
heart”.
Cardiac echocardiogram performed at 1 day of age re-
vealed a small patent ductus arteriosus (PDA) reported
to be normal for age. Brain magnetic resonance imaging
(MRI) without contrast revealed semilobar holoprosen-
cephaly. Renal ultrasound at two days of age revealed
grade two hydronephrosis of the right kidney. She was
discharged to home hospice and re-admitted at 1 month
18 days of age for evaluation of breakthrough seizures.
Neurology consult revealed that she was unable to
track or coo, but was able to lift her head when prone.
She was also noted to have truncal and appendicular
hypotonia. Electroencephalography (EEG) demonstrated
diffuse, nonspecific abnormalities with diffuse sharply
contoured waves, suggestive of generalized, nonspecific
cortical dysfunction. At discharge, she was also noted to
have temperature instability. At 5 months of age, she was
noted by otolaryngology to have plagiocephaly and upper
airway restriction and severe laryngomalacia, which was
treated by laser supraglottoplasty. See Table 1 for a com-
parison of the patient’s features to features of 22q11 dele-
tion syndrome described previously.
Conventional and molecular cytogenetics
Array CGH on peripheral blood revealed an approxi-
mately 116 kb deletion of chromosome 22q11.21 [arr
22q11.21 (18,894,835–19,010,562) × 1] (Fig. 1). A review
of DECIPHER on 5/19/2015 revealed one case (285903)
that also included central nervous system abnormal-
ities. Phenotypic findings included aggressive behavior,
dysgenesis of corpus callosum, global developmental
delay, hypertelorism, joint laxity, motor delay, narrow
palate, pes planus, and short stature. In addition, a
Fig. 1 Duplication and deletion on 22q11 in presented cases. a 22q11.21 deletion [arr 22q11.21 (18,894,835-19,010,562)x1]. b 22q11.21 duplication
[arr 22q11.21 (18,894,835-19,010,562)x3]
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review of dbVar (http://www.ncbi.nlm.nih.gov/dbvar/)
revealed case nsv931660 with a similar deletion (chr22:
18916842-19004772) which was classified as pathogenic
and phenotypic features included developmental delay
and/or other significant developmental or morphological
phenotypes.
Parental array CGH analysis was not performed at
the time of this report as it was declined by the family.
Fluorescence in situ hybridization (FISH) analysis on
peripheral blood revealed no interstitial deletion or du-
plication detected using a DNA probe (LSI TUPLE1
from Vysis/Abbott, Inc.) specific for the DiGeorge syn-
drome region of chromosome 22q11.2. Routine karyotype




Human reference genomic DNA was obtained through
Agilent Technologies (Agilent Technologies, Santa Clara,
CA, USA). The patients’ DNA and reference DNA were
labeled with either cyanine 3 (Cy-3) or cyanine 5 (Cy-5)
following the standard protocol provided by Agilent.
Equivalent labeling DNA products were mixed together
and were loaded onto Agilent’s 2 × 400 K oligo micro-
array chip, which is built based on GRCh37/hg19 (Agi-
lent Technologies, Santa Clara, CA, USA). The slide
was incubated in a hybridization oven at 67 °C for 40 h.
Slides were then washed and scanned by using a Nimble-
Gen MS 200 Microarray Scanner (NimbleGen System Inc,
Madison, WI, USA). Image was analyzed using CytoGe-
nomics 2.7 software (Agilent Technologies, Santa Clara,
CA, USA).
FISH analysis
Fluorescence in situ hybridization (FISH) analysis was
performed following standard clinical laboratory proto-
col using a DNA probe (LSI TUPLE1 from Vysis/Abbott
Laboratories, Inc.) specific for the DiGeorge syndrome
region of chromosome 22q11.2.
Routine karyotype analysis
Routine karyotype analysis was performed following stand-
ard clinical laboratory procedure.
Conclusions
We present two cases of 22q11.21 alterations with du-
plication in one and deletion in the second, and of
similar, small size and location (Fig. 2), both with cen-
tral nervous system abnormalities rarely reported in
cases of 22q11 alterations. The first patient has a small
(115 kb) duplication of 22q11 [arr 22q11.21 (18,894,835–
19,010,562) × 3], attention deficit-hyperactivity disorder,
autism spectrum disorder and sensory processing disorder,
and developmental language disorder, and was found to
have Chiari I malformation on MRI. While Chiari I mal-
formation has been previously reported in 22q11 deletion
syndrome [11], this is the first report, to our knowledge,
of a patient with 22q11 duplication and Chiari I malfor-
mation. In addition, it is the only case identified to have
duplication of this region without additional alterations.
The second patient has a small (116 kb) deletion of
22q11 [arr 22q11.21 (18,894,835–19,010,562) × 1], seizure
disorder, semilobar holoprosencephaly, microcephaly, cleft
lip, grade two hydronephrosis of the right kidney, plagioce-
phaly, and severe laryngomalacia. While there are previous
reports of single median incisor, which is associated with
holoprosencephaly, and fetal findings of holoprosencephaly
Fig. 2 Location of the duplication seen in Case 1 and deletion seen in Case 2. Figure adapted from Shaikh et al. [18] and http://genome.ucsc.edu [19]
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in cases diagnosed with 22q11 deletion syndrome, clinical
reports of patients with 22q11 deletion syndrome and
holoprosencephaly are rare.
Small deletions and duplications in 22q11 are increas-
ingly being reported with advancing microarray technol-
ogy. As additional patients are reported, knowledge
regarding genotype-phenotype correlations will aid in the
clinical management of future patients with these mo-
lecular cytogenetic findings. With this report, we aim to
contribute to this growing knowledge base and add these
reported central nervous system abnormalities to the
clinical features described. However, without additional
research it is unknown if the above findings are directly
related to the described alteration of chromosome 22q11
or coincidental findings, given the phenotypic variability
of both deletions and duplication of 22q11 region. Thus,
the pathogenicity of the described alterations remains un-
clear. Areas of future research would benefit from add-
itional analysis of the described regions with inclusion of
the phenotypic findings described in this case report.
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